DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Ascomycin is an investigational drug.
There have been 3 clinical trials for Ascomycin. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2004.
The most common disease conditions in clinical trials are Dermatitis, Atopic, Dermatitis, and Eczema. The leading clinical trial sponsors are Novartis, University of Leipzig, and [disabled in preview].
Recent Clinical Trials for Ascomycin
|Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis||Novartis||Phase 3|
|Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis||Novartis||Phase 3|
|Cutaneous Lupus Erythematosus and Elidel||Novartis||N/A|